Ningxia: RMB 2 million will be added for those who pass the consistency evaluation drug Award

Source: China Pharmaceutical News 2016-11-8 Ningxia is located in the northwest, and the pharmaceutical industry is still in a low level development state of "small, scattered and weak" in general In order to help enterprises seize the opportunity and carry out the consistency evaluation of generic drugs smoothly, the food and Drug Administration of Ningxia Hui Autonomous Region has made a lot of efforts "For each drug (variety) that has passed the evaluation, 2 million yuan will be awarded and supplemented For those who have entered the work procedure of generic drug consistency evaluation, 10% of the prize and subsidy funds can be allocated in advance." Recently, the "heart strengthening needle" of Ningxia Hui Autonomous Region government has not only injected a strong impetus for Ningxia pharmaceutical manufacturers to carry out the evaluation of generic drug consistency, but also highlighted the determination of Ningxia to jointly promote the evaluation of generic drug consistency Ningxia is located in the northwest, the pharmaceutical industry in general is still in a "small, scattered, weak" state of low-level development In order to help enterprises seize the opportunity and smoothly carry out the consistency evaluation of generic drugs, the food and Drug Administration of Ningxia Hui Autonomous Region held a symposium on relevant production enterprises, through face-to-face communication with the person in charge of the enterprise and technical personnel, to conduct a comprehensive survey of the enterprise's varieties, processes, production capacity, evaluation work related plans, etc In view of the situation of "lack of funds, difficult technology, less clinic and long time limit" reflected by the enterprise, the Autonomous Region Bureau communicates with the economic and Information Commission, health and Family Planning Commission and other departments of the autonomous region, and decides that the Autonomous Region Bureau shall actively cooperate with the economic and Information Commission, development and reform, science and technology and other departments to provide funds and project support to solve the "lack of funds"; arrange the professional and technical personnel of the Drug Inspection Institute of the autonomous region to the enterprise“ Point to point "on-site guidance to solve the" technical difficulties "; coordinate the health and family planning departments and relevant clinical trial institutions to prioritize the bioequivalence test applied for by the enterprises in the area, encourage the top three hospitals in the area to apply for the clinical trial institutions to solve the" clinical shortage "; compress the data collection, on-site inspection and verification and one-time import of reference preparations and other approval issues to solve the time limit "Long time limit" At present, Ningxia Regional Bureau has drafted the work procedure for application of supplementary funds for quality and efficacy consistency evaluation of generic drugs in Ningxia pharmaceutical manufacturers, and the work of consistency evaluation of generic drugs is being carried out in an orderly manner (Liu Jianjun, LV Li)